Blood hepatocyte growth factor levels in patients with end-stage renal disease.

被引：0
|
作者：
Lohr, JW
Lee, TP
Mookerjee, BK
机构：
[1] SUNY BUFFALO,DEPT MED,BUFFALO,NY
[2] VAMC,BUFFALO,NY
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 1996年 / 44卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A372 / A372
页数：1
相关论文
共 50 条
  • [21] Usefulness of dipyridamole SPECT myocardial imaging in patients with end-stage renal disease.
    Kim, HJ
    Lee, TW
    Hong, SP
    Lim, CG
    Kim, MJ
    KIDNEY INTERNATIONAL, 1999, 55 (04) : 1619 - 1620
  • [22] Frailty, Inflammation, and Waitlist Mortality among Patients with End-Stage Renal Disease.
    DeMarco, M. McAdams
    Ying, H.
    Thomas, A.
    Warsame, F.
    Shaffer, A.
    Haugen, C.
    Wang, J. Garonzik
    Desai, N.
    Norman, S.
    Segev, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 668 - 668
  • [23] National Trends in Bariatric Surgical Practice for Patients with End-Stage Renal Disease.
    Sheetz, K. H.
    Woodside, K. J.
    Shahinian, V. B.
    Dimick, J. B.
    Waits, S. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 440 - 440
  • [24] Access To The Kidney Transplant Waitlist For Patients With Hiv And End-stage Renal Disease.
    Shaffer, A. A.
    Ying, H.
    Chu, N.
    Thomas, A. G.
    Haugen, C.
    Norman, S.
    Segev, D. L.
    McAdams-DeMarco, M. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 508 - 509
  • [25] ELEVATED LP(A) LEVELS IN PATIENTS WITH END-STAGE RENAL-DISEASE
    THILLET, J
    DOUCET, C
    ISSAD, B
    ALLOUACHE, M
    CHAPMAN, JM
    JACOBS, C
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (04) : 620 - 621
  • [26] Serum Hepcidin Levels in Patients with End-Stage Renal Disease on Hemodialysis
    Rubab, Zille
    Amin, Huma
    Abbas, Khizer
    Hussain, Shabbir
    Ullah, Muhammad Ikram
    Mohsin, Shahida
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2015, 26 (01) : 19 - 25
  • [27] Treatment of osteoporosis in chronic kidney disease and end-stage renal disease.
    Miller P.D.
    Current Osteoporosis Reports, 2005, 3 (1) : 5 - 12
  • [28] Human fetuin-A levels and calcification risk index as novel indicators of cardiovascular disease and mortality in end-stage liver disease and end-stage renal disease.
    Nilson, NM
    Mullaney, S
    Thistlethwaite, P
    Gao, P
    Herold, D
    Wolf, P
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (03) : 462 - 463
  • [29] The pharmacokinetics of fexofenadine but not midazolam are altered in end-stage renal disease.
    Nolin, T. D.
    Frye, R. F.
    Sadr, H.
    Le, P.
    Himmelfarb, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S58 - S58
  • [30] Emphysematous gastritis in a diabetic patient with end-stage renal disease.
    Thayil, JJ
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S142 - S143
12345